tiprankstipranks
aTyr Pharma announces third positive DSMB review for efzofitimod
PremiumThe FlyaTyr Pharma announces third positive DSMB review for efzofitimod
2M ago
aTyr Pharma to present preclinical research on ATYR0101 at symposia on Firbosis
Premium
The Fly
aTyr Pharma to present preclinical research on ATYR0101 at symposia on Firbosis
2M ago
aTyr Pharma initiated with a Buy at Lucid Capital
Premium
The Fly
aTyr Pharma initiated with a Buy at Lucid Capital
3M ago
CVS Health upgraded, Mobileye downgraded: Wall Street’s top analyst calls
PremiumThe FlyCVS Health upgraded, Mobileye downgraded: Wall Street’s top analyst calls
5M ago
aTyr Pharma announces publication of Phase 1b/2a clinical trial ofefzofitimod
Premium
The Fly
aTyr Pharma announces publication of Phase 1b/2a clinical trial ofefzofitimod
5M ago
Dollar Tree downgraded, Roku upgraded: Wall Street’s top analyst calls
Premium
The Fly
Dollar Tree downgraded, Roku upgraded: Wall Street’s top analyst calls
6M ago
aTyr Pharma announces research study with Stanford Medicine
PremiumThe FlyaTyr Pharma announces research study with Stanford Medicine
7M ago
aTyr Pharma potentially poised to break out in 2025, says RBC Capital
Premium
The Fly
aTyr Pharma potentially poised to break out in 2025, says RBC Capital
7M ago
aTyr Pharma completes enrollment in Phase 3 EFZO-FIT study
Premium
The Fly
aTyr Pharma completes enrollment in Phase 3 EFZO-FIT study
7M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100